| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
group | 0.360 | None | 1.000 | 1 | 0 | 2001 | 2007 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
group | 0.360 | None | 1.000 | 1 | 0 | 1999 | 2016 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 1996 | 2007 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 1999 | 2006 | ||||||||
|
ATPase copper transporting beta | 0.529 | 0.654 | 4.8E-30 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2001 | 2017 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2009 | 2016 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 1998 | 2016 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2004 | 2019 | |||||||||
|
stearoyl-CoA desaturase | 0.490 | 0.808 | 0.97 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
intraflagellar transport 88 | 0.621 | 0.654 | 7.1E-11 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 1997 | 2012 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 1999 | 2011 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2001 | 2012 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2003 | 2015 | ||||||||
|
Jun proto-oncogene, AP-1 transcription factor subunit | 0.442 | 0.885 | 6.0E-02 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2002 | 2017 | ||||||||
|
metastasis associated lung adenocarcinoma transcript 1 | 0.435 | 0.846 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2016 | 2017 | |||||||||
|
heme oxygenase 1 | 0.381 | 0.923 | 9.7E-03 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2004 | 2006 | ||||||||
|
nuclear paraspeckle assembly transcript 1 | 0.502 | 0.769 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2016 | 2019 | |||||||||
|
hepatocellular carcinoma up-regulated long non-coding RNA | 0.606 | 0.538 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2017 | 2019 | |||||||||
|
keratin 8 | 0.517 | 0.654 | 2.4E-08 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2009 | 2013 | ||||||||
|
egl-9 family hypoxia inducible factor 3 | 0.575 | 0.654 | 9.5E-03 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
microRNA 29a | 0.459 | 0.808 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2017 | |||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2010 | ||||||||
|
host cell factor C1 | 0.601 | 0.692 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
annexin A2 | 0.453 | 0.808 | 9.8E-05 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2015 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 1996 | 2018 |